Novo A/S as of March 31, 2015
Portfolio Holdings for Novo A/S
Novo A/S holds 15 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 27.2 | $320M | 3.0M | 107.25 | |
| Ophthotech | 19.4 | $229M | 4.9M | 46.53 | |
| Vanguard Intl Equity Index F Ftse Europe Etf (VGK) | 9.7 | $114M | 2.1M | 54.22 | |
| Inogen (INGN) | 9.7 | $114M | 3.5M | 31.99 | |
| Nevro (NVRO) | 8.9 | $105M | 2.2M | 47.93 | |
| Alder Biopharmaceuticals | 7.9 | $92M | 3.2M | 28.86 | |
| Otonomy | 6.5 | $77M | 2.2M | 35.36 | |
| Flexion Therapeutics | 4.4 | $51M | 2.3M | 22.52 | |
| Wright Med Group Right 03/01/2019 (Principal) | 1.7 | $20M | 4.7M | 4.30 | |
| Akebia Therapeutics (AKBA) | 1.4 | $17M | 1.5M | 11.11 | |
| Tokai Pharmaceuticals | 1.1 | $13M | 1.2M | 11.30 | |
| Aerie Pharmaceuticals | 1.1 | $13M | 420k | 31.34 | |
| Tetraphase Pharmaceuticals | 0.7 | $8.5M | 231k | 36.64 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $2.2M | 128k | 16.86 | |
| Intersect Ent | 0.0 | $0 | 0 | 0.00 |
